Alcon爱尔康品牌怎么样 申请店铺

我要投票 Alcon爱尔康在医疗器械行业中的票数:1125 更新时间:2026-01-24
Alcon爱尔康是哪个国家的品牌?「Alcon爱尔康」是爱尔康(中国)眼科产品有限公司旗下著名品牌。该品牌发源于美国,在1945年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Alcon爱尔康品牌出海!将品牌入驻外推网,定制Alcon爱尔康品牌推广信息,可以显著提高Alcon爱尔康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Alcon爱尔康怎么样

始于1945年美国,2008年被诺华公司收购,全球眼科领域的领先者,专业研究、发展、服务及制造光学及眼科产品的世界级厂商


爱尔康公司 (Alcon Laboratories, Inc.) 成立于1945年,是全球较大的眼科药品与医疗器械专业公司。在全球75个国家和地区设有分公司,拥有15,000多名员工,5个研发中心,14个生产工厂,产品销售遍及180多个国家和地区。

2008诺华公司收购眼部护理公司Alcon股份。合并完成后,爱尔康成为诺华旗下第二大的部门。视康(CIBA VISION)和选出的数种诺华眼科医药将被整合进爱尔康,从而形成销售额超过87亿美元、覆盖超过70%的眼科护理领域的组织。

爱尔康的使命是通过创新型产品,提高视觉质量,提高生活品质。这个使命意味着爱尔康22000多名员工为“保护、恢复和提高视力”的目标进行着不懈的努力与奋斗,使散光治疗,青光眼治疗,近视眼激光视力恢复矫正等等技术得到更好,努力改善更多人的视力健康。

在全球范围内,爱尔康有近2000名员工专注于研发工作,以满足世界上迫切的眼部护理需求。

此外,爱尔康与眼科保健专业人士和人道主义组织建立了紧密的合作关系,共同专注于医疗使命并在世界上需要救助的社区进行防盲活动。世界上存在着很多未解决的眼科问题,全世界有数百万人不能得到常规性眼科护理,大量实质性工作亟待完成。基于数十年的专业经验,爱尔康将继续专注于促进眼科保健行业的发展。

爱尔康于1995年作为法人实体进入中国。今天,爱尔康中国在全国范围内拥有700余名员工服务于我们的眼科保健专家。我们的企业目标是在手术产品、药品及视力保健领域成为患者的选择。爱尔康中国一贯秉承其对中国眼科医生及患者的承诺,不断加强相互间的合作,携手共创辉煌的明天。

爱尔康中国同中华医学会眼科学分会紧密合作,举办各种规模及各种类型的学术研讨会,全国眼科年会,以及国际眼科会议;为国内眼科医生的学术交流活动创造平台,为推动中国眼科事业的发展做出不懈的努力。此外,爱尔康中国还同中国残联,健康快车等慈善机构紧密合作,支持各种扶贫项目,为中国的防盲治盲工作贡献力量。


Founded in 1945 in the United States and acquired by Novartis in 2008, Alcon laboratories, Inc., a global leader in ophthalmology and a world-class manufacturer specializing in research, development, service and manufacturing of optical and ophthalmic products, was established in 1945 as the world's largest professional company of ophthalmic drugs and medical devices. It has branches in 75 countries and regions, more than 15000 employees, 5 R & D centers, 14 production plants, and product sales in more than 180 countries and regions. In 2008, Novartis acquired the shares of Alcon, an eye care company. After the merger, Alcon became the second largest division of Novartis. Cibavision and several selected Novartis ophthalmic medicines will be integrated into Alcon to form an eye care organization with sales of over $8.7 billion and coverage of over 70%. Alcon's mission is to improve visual quality and quality of life through innovative products. This mission means that more than 22000 employees of Erkang are making unremitting efforts and struggles for the goal of "protecting, restoring and improving vision", so that astigmatism treatment, glaucoma treatment, myopia laser vision restoration and correction and other technologies can be better, and efforts can be made to improve the visual health of more people. Globally, Alcon has nearly 2000 employees focused on R & D to meet the world's urgent eye care needs. In addition, Alcon has established a close partnership with eye care professionals and humanitarian organizations to focus on medical missions and carry out anti blindness activities in communities in need of assistance around the world. There are many unsolved ophthalmic problems in the world, millions of people in the world can not get routine ophthalmic care, and a lot of substantive work needs to be completed. Based on decades of professional experience, Alcon will continue to focus on promoting the development of eye care industry. Alcon entered China as a legal entity in 1995. Today, Alcon China has more than 700 employees serving our eye care experts nationwide. Our business goal is to be the choice of patients in the field of surgical products, drugs and vision care. Elkon China has always adhered to its commitment to Chinese ophthalmologists and patients, and constantly strengthened mutual cooperation to create a brilliant tomorrow hand in hand. Erkang China, in close cooperation with the ophthalmology branch of the Chinese Medical Association, has held various scale and types of academic seminars, national annual ophthalmology conference and international ophthalmology conference, created a platform for academic exchange activities of domestic ophthalmologists, and made unremitting efforts to promote the development of ophthalmology in China. In addition, elkham China has also worked closely with China Disabled Persons' Federation, health express and other charities to support various poverty alleviation projects and contribute to China's anti blindness work.

本文链接: https://brand.waitui.com/ed7309435.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

5分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

5分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

5分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

5分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

5分钟前

本页详细列出关于Alcon爱尔康的品牌信息,含品牌所属公司介绍,Alcon爱尔康所处行业的品牌地位及优势。
咨询